The clinical study will evaluate MRK's experimental antibody treatment in patients with diabetic macular edema, a major cause of vision loss.
Vous n'êtes pas connecté
BioStem Technologies Inc, a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental─derived biologics for advanced wound care, announced that the
The clinical study will evaluate MRK's experimental antibody treatment in patients with diabetic macular edema, a major cause of vision loss.
Learn about the latest research linking insulin and metformin in diabetic foot ulcer exudates, paving the way for innovative treatment approaches
Relay Therapeutics, Inc., a clinical─stage precision medicine company transforming the drug discovery process by combining leading─edge...
Competitive: ICON Strategic Solutions: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...
Competitive: ICON Strategic Solutions: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...
Diabetes can affect a person’s gait, potentially leading to severe foot complications. A study presented at the European Society of Cardiology’s...
Competitive: ICON Plc: Study Start Up Associate, Clinical Site Activation - Poland, Croatia, Latvia ICON plc is a world-leading healthcare...
Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural...
Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural...
Competitive: Life Science People: Our client is a pioneering pharmaceutical company dedicated to transforming medicine through advanced drug delivery...